Concepedia

Jae Werndli

JW

Statistics

Publications

13

Citations

516

H-Index

13

Active since

2005

Affiliations

University of Wisconsin–Madison(Current)

University of Wisconsin Carbone Cancer Center

Aspirus Wausau Hospital

University of Wisconsin–Green Bay

Regional Cancer Center

Jae Werndli is an author at University of Wisconsin–Madison specializing in oncology, medicine, and chemotherapy.

Publications per year

2005–2017

13

Publications

13

Bortezomib-Resistant Nuclear Factor-κB Activity in Multiple Myeloma Cells

Stephanie Markovina, Natalie S. Callander, Shelby L. O’Connor et al. · Molecular Cancer Research · 2008 · 146 citations · Full text

, , +13

Maintenance rituximab following induction chemoimmunotherapy may prolong progression-free survival in mantle cell lymphoma: a pilot study from the Wisconsin Oncology Network

Brad S. Kahl, Walter Longo, Jens C. Eickhoff et al. · Annals of Oncology · 2006 · 113 citations · Full text

, , +12

VcR‐CVAD induction chemotherapy followed by maintenance rituximab in mantle cell lymphoma: a Wisconsin Oncology Network study

Christopher G. Peterson, Sangbum Choi, Jens C. Eickhoff et al. · British Journal of Haematology · 2011 · 51 citations · Full text

, , +12

Maintenance rituximab following induction chemo-immunotherapy for mantle cell lymphoma: long-term follow-up of a pilot study from the Wisconsin Oncology Network

Vaishalee P. Kenkre, Walter L. Long, Jens C. Eickhoff et al. · Leukemia & lymphoma/Leukemia and lymphoma · 2011 · 40 citations

, , +16

Phase II study of arsenic trioxide and ascorbic acid for relapsed or refractory lymphoid malignancies: a Wisconsin Oncology Network study

JE Chang, PM Voorhees, JM Kolesar et al. · Hematological Oncology · 2008 · 35 citations · Full text

, , +15

1–5 of 13